How protein-based COVID vaccines could change the pandemic
Elie Dolgin • November 8, 2021
Jabs from Novavax and other biotech firms are coming. Scientists say they have a lot to offer.
Continue reading at Nature.
Circulating biomarkers are quickly becoming a crucial part of diagnosis and disease monitoring for physicians, researchers — and even some consumers.
Zebras and giraffes offer one another protection without food competition.